Article
The effects of telomerase inhibition on prostate tumor‐initiating cells
24 Feb 2010
Abstract excerpt
Prostate cancer is the most common malignancy in men, and patients with metastatic disease have poor outcome even with the most advanced therapeutic approaches. Most cancer therapies target the bulk tumor cells, but may leave intact a small population of tumor-initiating cells (TICs), which are believed to be responsible for the subsequent relapse and metastasis. Using specific surface markers (CD44, integrin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
